Pardo Geoffrey B
SEC Form 4 insider trading activity
Pardo Geoffrey B has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Feb 11, 2026.
On the most recent filing, Pardo Geoffrey B is listed as Director at SpyGlass Pharma, Inc. Inside the rolling window, Pardo Geoffrey B reported 1 open-market purchase totaling $5.0M in SGP and no open-market sales.
Companies traded
Other insiders at SGP
Insider Buying
$5.0M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Pardo Geoffrey B made?
Pardo Geoffrey B has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Pardo Geoffrey B trade?
Pardo Geoffrey B has filed SEC Form 4 disclosures for 1 company, including SGP.
When was Pardo Geoffrey B's most recent SEC Form 4 filing?
Pardo Geoffrey B's most recent SEC Form 4 filing on Tracefour is dated Feb 11, 2026.
What is Pardo Geoffrey B's total buy and sell value in the current window?
Inside the rolling retention window, Pardo Geoffrey B bought $5.0M and sold $0 based on SEC Form 4 filings.
What was Pardo Geoffrey B's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 312,500 SGP shares on 2026-02-09, worth $5.0M, per SEC Form 4 filings.